Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

72.15
-2.0900-2.82%
Post-market: 72.150.00000.00%17:50 EDT
Volume:1.95M
Turnover:141.16M
Market Cap:11.92B
PE:-30.32
High:74.05
Open:74.00
Low:71.87
Close:74.24
52wk High:86.74
52wk Low:23.95
Shares:165.19M
Float Shares:164.00M
Volume Ratio:0.70
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3800
EPS(LYR):-2.3812
ROE:-70.80%
ROA:-7.31%
PB:24.37
PE(LYR):-30.30

Loading ...

BUZZ-Ionis drops after forecasting 2026 revenue below expectations

Reuters
·
Feb 25

Ionis Pharmaceuticals reports Q4 EPS ($1.41), consensus ($1.22)

TIPRANKS
·
Feb 25

Ionis Pharmaceuticals Shares Down 5.8% Premarket After Co Forecast FY26 Revenue Below Estimates

THOMSON REUTERS
·
Feb 25

Ionis Pharma Q4 revenue beats expectations, helped by TRYNGOLZA EU launch

Reuters
·
Feb 25

GUIDANCE: (IONS) Ionis Pharmaceuticals Expects Full Year 2026 Revenue Range $800M-$825M, vs. FactSet Est of $915M

MT Newswires Live
·
Feb 25

Stock Track | Ionis Pharmaceuticals Plunges 5.20% in Pre-Market on Widening Q4 Loss

Stock Track
·
Feb 25

Earnings Flash (IONS) Ionis Pharmaceuticals Posts Q4 Revenue $203M, vs. FactSet Est of $157.7M

MT Newswires Live
·
Feb 25

Ionis Q4 revenue USD 203 million, up 64% on commercial revenue

Reuters
·
Feb 25

Ionis Pharmaceuticals Q4 Adj. EPS $(1.15) Beats $(1.32) Estimate, Sales $203.000M Beat $156.094M Estimate

Benzinga
·
Feb 25

BRIEF-Ionis Pharmaceuticals Q4 Revenue USD 203 Million Vs. IBES Estimate USD 156.1 Million

Reuters
·
Feb 25

Ionis Pharmaceuticals Q4 Adjusted Operating Expenses USD 375 Million

THOMSON REUTERS
·
Feb 25

Ionis Pharmaceuticals Inc: Outlook 2026 Revenue $800- $825 Mln

THOMSON REUTERS
·
Feb 25

Ionis Pharmaceuticals Q4 Operating Income USD -215 Million

THOMSON REUTERS
·
Feb 25

Ionis Pharmaceuticals Q4 Operating Expenses USD 418 Million

THOMSON REUTERS
·
Feb 25

U.S. Earnings Preview: Before Market Open Feb. 25

Dow Jones
·
Feb 25

Ionis Pharmaceuticals to Present at Upcoming Investor Conferences

Reuters
·
Feb 19

A Look At Ionis Pharmaceuticals (IONS) Valuation After Recent Share Price Strength And Mixed Analyst Signals

Simply Wall St.
·
Feb 19

Earning Preview: Ionis Pharmaceuticals this quarter’s revenue is expected to increase by 13.44%, and institutional views are bullish

Earnings Agent
·
Feb 18

Ionis Pharmaceuticals Inc. updates time for financial results webcast

Reuters
·
Feb 18

Ionis Updates Time for Fourth Quarter and Full Year 2025 Financial Results Webcast

THOMSON REUTERS
·
Feb 18